News

The Research Day offers scientists in Freiburg the opportunity to acquire up-to-date information on career paths and funding options, to present their research projects, to attend talks by renowned Freiburg scientists, and to interact and network with one another.

Clarivate ranking confirms international leadership in research
Two scientists from the CRC 1160 are among the Highly Cited Researchers 2025. This means they are counted among the most influential researchers worldwide. The award is given annually by Clarivate Analytics and is based on scientific publications that are most frequently cited in the Web of Science database. It is considered an important indicator of scientific excellence and international visibility in medical research.

CRC1160 immunologist, Stephan Ehl (A01), explains why the latest Nobel Prize in Medicine honors groundbreaking discoveries about the immune system’s “brake mechanism.” Professor Stephan Ehl highlights how research on regulatory T cells transforms therapy for autoimmune diseases and cancer, offering new hope for patients.

Prof. Marta Rizzi (B02, CRC 1160) has been honored with the John Grube Research Award by the German Society for Rheumatology (DGRh) and the John Grube Foundation e.V. for her outstanding work on ANCA-associated vasculitides.

Annual CRC 1160 retreat in St. Peter.

Die jährliche Schulveranstaltung mit Vorträgen über das Immunsystem von Ärzten und Wissenschaftlern des CCI & SFB 1160 findet am 06. Juni 2025 wieder statt.

Prof. Dr. Marco Prinz (C03) has been honoured with the University Medal by Rector Prof. Dr. Kerstin Krieglstein in recognition of his outstanding contributions to the University of Freiburg.

Dr. Katrin Kierdorf, scientist of the CRC 1160 (C05N), has been accepted into the Heisenberg Programme from the German Research Foundation (DFG).

Prof. Dr. Dr. Melanie Börries, principal investigator in the CRC 1160 (Z02), has been awarded the Deutschen Krebspreis 2025 in the category “Translational Research.” This prestigious recognition highlights her groundbreaking work in the field of personalized cancer therapy.

Prof. Dr. Robert Zeiser (Bo9, B10N) has been honored with the esteemed E. Donnall Thomas Lecture Prize by the American Society for Transplantation and Cellular Therapy.

Was macht unser Immunsystem zum Superhelden – und wo liegen seine Schwächen? In der neuen Folge des Podcasts “Code des Lebens” erklärt Prof. Dr. Bodo Grimbacher (B05) die faszinierenden Mechanismen des Immunsystems, die Rolle des Mikrobioms und die Herausforderungen bei seltenen Autoimmunerkrankungen.

Das Centrum für Chronische Immundefizienz (CCI) am Universitätsklinikum Freiburg unter der Leitung von Prof. Dr. Stephan Ehl (A01) ist führend in der Erforschung genetischer Immundefekte – einer Gruppe seltener Erkrankungen, die das Immunsystem schwächen und komplexe Diagnosen erfordern. Mit dem Europäischen Immundefektregister bietet das CCI ein wertvolles Werkzeug, um Krankheitsverläufe zu dokumentieren und Therapieansätze zu verbessern.

Prof. Dr. Jean-Laurent (The Rockefeller University, New York, USA) will talk about “Human auto-Abs neutralizing type I IFNs: Strong, common, and global determinants of viral diseases” on February 26, 2025.

Wie können Register die Forschung und Versorgung seltener Erkrankungen wie Immundefekten verbessern? In einem spannenden Podcast diskutiert Prof. Dr. Stephan Ehl (A01) mit Hans-Holger Bleß (fbeta GmbH) über internationale Vernetzung, Datenqualität, nachhaltige Finanzierung und technologische Innovationen, die die Registerforschung revolutionieren könnten.

In the Lady Mary Montagu lecture series of the DGfI Commission on Gender Equality and Career Development, Prof. Dr. Susana Minguet (B01) will share her exciting research on “Harnessing TCR Discoveries for the Next GEneration of Immunotherapies”.